share_log

康弘药业:北京市通商(深圳)律师事务所关于成都康弘药业集团股份有限公司2023年股票增值权激励计划股票增值权授予事项的法律意见书

Kanghong Pharmaceutical: Legal Opinion of Beijing Commerce (Shenzhen) Law Firm on the granting of stock value-added rights in the 2023 Stock Value-added Incentive Plan of Chengdu Kanghong Pharmaceutical Group Co., Ltd.

SZSI ·  Feb 7
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more